We have observed
5 EP applications
Ian Gordon Berry
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after June 24, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
CHROMENONE COMPOUNDS AS PI 3 -KINASE INHIBITORS FOR THE TREATMENT OF CANCER
2 - (2, 4, 5 - SUBSTITUTED -ANILINO) PYRIMIDINE DERIVATIVES AS EGFR MODULATORS USEFUL FOR TREATING CANCER
NOVEL TICAGRELOR CO - CRYSTAL
COMBINATION THERAPY FOR THE TREATMENT OF NOSOCOMIAL PNEUMONIA